Cardiovascular toxicity of Citrus aurantium in exercised rats

Cardiovascular Toxicology

Volumn 13, Issue 3, 2013, Pages 208-219

  Hansen, Deborah K ^a   George, Nysia I ^a   White, Gene E ^b   Abdel Rahman, Ali ^a   Pellicore, Linda S ^a   Fabricant, Daniel ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Toxicologic Pathology Associates   (United States)

Author keywords

Bitter orange; Blood pressure; Cardiotoxicology; Citrus aurantium; Heart rate; Weight loss

Indexed keywords

CAFFEINE; OXEDRINE; SOUR ORANGE EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CARDIOTOXICITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELEVATED BLOOD PRESSURE; FEMALE; FOOD INTAKE; HEART RATE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; RAT; SYSTOLIC BLOOD PRESSURE; TOXICITY TESTING; TREADMILL EXERCISE; WEIGHT GAIN;

CITRUS AURANTIUM; EPHEDRA; RATTUS;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE; BODY WEIGHT; CAFFEINE; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM STIMULANTS; CITRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EATING; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; HEART RATE; LONG QT SYNDROME; PHYSICAL CONDITIONING, ANIMAL; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; SYMPATHOMIMETICS; SYNEPHRINE;

EID: 84884280828     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-013-9199-x     Document Type: Article

References (39)

1. Shekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M. J., et al. (2003). Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance. Journal of the American Medical Association, 289, 1537-1545.
2. Fugh-Berman, A., & Myers, A. (2004). Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: Current status of clinical and basic research. Experimental Biology and Medicine, 229, 698-704.
3. Allison, D. B., Cutter, G., Poehlman, E. T., Moore, D. R., & Barnes, S. (2005). Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain? International Journal of Obesity, 29, 443-446.
4. Santana, J., Sharpless, K. E., & Nelson, B. C. (2008). Determination of para-synephrine and meta-synephrine positional isomers in bitter orange-containing dietary supplements by LC/UV and LC/MS/MS. Food Chemistry, 109, 675-682.
5. Pellati, F., & Benvenuti, S. (2007). Chromatographic and electrophoretic methods for the analysis of phenethylamine alkaloids in Citrus aurantium. Journal of Chromatography A, 1161, 71-88.
6. Stohs, S. J., Preuss, H. G., & Shara, M. (2011). The safety of Citrus aurantium (Bitter Orange) and its primary protoalkaloide p-synephrine. Phytotherapy Research, 25, 1421-1428.
7. Stohs, S. J., Preuss, H. G., & Shara, M. (2011). A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects. Oxidative Medicine and Cellular Longevity,. doi: 10.1155/2011/482973.
8. Brown, C. M., McGrath, J. C., Midgley, J. M., Muir, A. G. B., O'Brien, J. W., Thonoor, C. M., et al. (1988). Activities of octopamine and synephrine stereoisomers on α-adrenoceptors. British Journal of Pharmacology, 93, 417-429.
9. Jordan, R., Midgley, J. M., Thonoor, C. M., & Williams, C. M. (1987). Beta-adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig atria and trachea. Journal of Pharmacy and Pharmacology, 39, 752-754.
10. Haaz, S., Fontaine, K. R., Cutter, G., Limdi, N., Perumean-Chaney, S., & Allison, D. B. (2006). Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: An update. Obesity Review, 7, 79-88.
11. 3-adrenoreceptors by octopamine: Comparative studies in mammalian fat cells. Naunyn Schmiedeberg's Archives of Pharmacology, 359, 310-321.
12. Fang, Y.-S., Shan, D.-M., Liu, J.-W., Xu, W., Li, C.-L., Wu, H.-Z., et al. (2009). Effect of constituents from Fructus aurantii immaturus and Radix Paeoniae Alba on gastrointestinal movement. Plant Medicine, 75, 24-31.
13. Nasir, J. M., Durning, S. J., Ferguson, M., Barold, H. S., & Haigney, M. C. (2004). Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine. Mayo Clinic Proceedings, 79, 1059-1062.
14. Nykamp, D. L., Fackih, M. N., & Compton, A. L. (2004). Possible association of acute later-wall myocardial infarction and bitter orange supplement. Annals of Pharmacotherapy, 38, 812-816.
15. Thomas, J. E., Munir, J. A., McIntyre, P. Z., & Ferguson, M. A. (2009). STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement. A case report and review of the literature. Texas Heart Institute Journal, 36, 586-590.
16. Bouchard, N. C., Howland, M. A., Greller, H. A., Hoffman, R. S., & Nelson, L. S. (2005). Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine. Mayo Clinic Proceedings, 80, 541-545.
17. Gange, C. A., Madias, C., Felix-Getzik, E. M., Weintraub, A. R., & Estes, N. A. M., I. I. I. (2006). Variant angina associated with bitter orange in a dietary supplement. Mayo Clinic Proceedings, 81, 545-548.
18. Firenzuoli, F., Gori, L., & Galapai, C. (2005). Adverse reaction to an adrenergic herbal extract (Citrus aurantium). Phytomedicine, 12, 247-248.
19. Gray, S., & Woolf, A. D. (2005). Citrus aurantium used for weight loss by an adolescent with anorexia nervosa. Journal of Adolescent Health, 37, 415-416.
20. Holmes, R. O., & Tavee, J. (2008). Vasospasm and stroke attributable to ephedra-fee Xendadrine: Case report. Military Medicine, 173, 708-710.
21. Stephensen, T. A., & Sarlay, R., Jr. (2009). Ventricular fibrillation associated with use of synephrine containing dietary supplement. Military Medicine, 174, 1313-1319.
22. Sultan, S., Spector, J., & Mitchell, R. M. (2006). Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement. Mayo Clinic Proceedings, 81, 1630-1631.
23. Hansen, D. K., George, N. I., White, G. E., Pellicore, L. S., Abdel-Rahman, A., & Fabricant, D. (2012). Physiological effects following administration of Citrus aurantium for 28 days in rats. Toxicology and Applied Pharmacology, 261, 236-247.
24. NRC. (1996). Guide for the care and use of laboratory animals. Washington, DC: Institute for Laboratory Animal Resources.
25. Calapai, G., Firenzuoli, F., Saitta, A., Squadrito, F., Arlotta, M. R., Costantino, G., et al. (1999). Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: A preliminary report. Fitoterapia, 70, 586-592.
26. Arbo, M. D., Larentis, E. R., Linck, V. M., Aboy, A. L., Pimentel, A. L., Henriques, A. T., et al. (2008). Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine. Food and Chemical Toxicology, 46, 2770-2775.
27. Arbo, M. D., Schmitt, G. C., Limberger, M. F., Charao, M. F., Moro, A. M., Ribeiro, G. L., et al. (2009). Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice. Regulatory Toxicology and Pharmacology, 54, 114-117.
28. Reagan-Shaw, S., Nihal, M., & Ahmad, N. (2008). Dose translation from animal to human studies revisited. FASEB Journal, 22, 659-661.
29. Knight, C. A., Knight, I., Mitchell, D. C., & Zepp, J. E. (2004). Beverage caffeine intake in US consumers and subpopulations of interest: Estimates from the share of intake panel survey. Food and Chemical Toxicology, 42, 1923-1930.
30. Frary, C. D., Johnson, R. K., & Wang, M. Q. (2005). Food sources and intakes of caffeine in the diets of persons in the United States. Journal of the American Dietetic Association, 105, 110-113.
31. Andrews, K. W., Schweitzer, A., Zhao, C., Holden, J. M., Roseland, J. M., Brandt, M., et al. (2007). The caffeine contents of dietary supplements commonly purchased in the US: Analysis of 53 products with caffeine-containing ingredients. Analytical and Bioanalytical Chemistry, 389, 231-239.
32. Werle, E. O., Strobel, G., & Weicker, H. (1990). Decrease I rat cardiac beta1- and beta2-adrenoceptors by training and endurance exercise. Life Sciences, 46, 9-17.
33. Favret, F., Henderson, K. K., Clancy, R. L., Richalet, J.-P., & Gonzalez, N. C. (2001). Exercise training alters the effect of chronic hypoxia on myocardial adrenergic and muscarinic receptor number. Journal of Applied Physiology, 91, 1283-1288.
34. 2 muscarinic receptors in rat heart. Medicine and Science in Sports and Exercise, 36, 949-954.
35. Barbier, J., Reland, S., Ville, N., Rannou-Bekono, F., Wong, S., & Carre, F. (2006). The effects of exercise training on myocardial adrenergic and muscarinic receptors. Clinical Autonomic Research, 16, 61-65.
36. Ohiwa, N., Saito, T., Chang, H., Omori, T., Fujikawa, T., Asada, T., et al. (2006). Activation of A1 and A2 noradrenergic neurons in response to running in the rat. Neuroscience Letters, 395, 46-50.
37. Libonati, J. R., & MacDonnell, S. M. (2011). Cardiac β-adrenergic responsiveness with exercise. European Journal of Applied Physiology, 111, 2735-2741.
38. Haller, C. A., Duan, M., Jacob, P., I. I. I., & Benowitz, N. (2008). Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. British Journal of Clinical Pharmacology, 65, 33-840.
39. Sale, C., Harris, R. C., Delves, S., & Corbett, J. (2006). Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males. International Journal of Obesity, 30, 764-773.